Chronic Myelomonocytic Leukemia Active Not Recruiting Phase 2 Trials for Sirolimus (DB00877)

Also known as: Chronic myelomonocytic leukaemia / Chronic myelomonocytic leukemia with failed remission / Leukemia, Myelomonocytic, Chronic

IndicationStatusPhase
DBCOND0028572 (Chronic Myelomonocytic Leukemia)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03018223Calcineurin Inhibitor-Free GVHD Prevention Regimen After Related Haplo PBSCTPrevention
NCT01885689Clofarabine and Melphalan Before Donor Stem Cell Transplant in Treating Patients With Myelodysplasia, Acute Leukemia in Remission, or Chronic Myelomonocytic LeukemiaTreatment